← Evidence map

ArticleBritish journal of pharmacology1993

2-Naphthalenesulphonyl L-aspartyl-(2-phenethyl)amide (2-NAP)--a selective cholecystokinin CCKA-receptor antagonist.

R A Hull et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

1993

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

this papercites it

2-Naphthalenesulphonyl L-aspartyl-(2-phenethyl)amide (2-NAP)--a selective cholecystokinin CCKA-receptor antagonist. | OpenQuestion